<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04120155</url>
  </required_header>
  <id_info>
    <org_study_id>IPLP FJUNION</org_study_id>
    <nct_id>NCT04120155</nct_id>
  </id_info>
  <brief_title>Effect of Inferior Pulmonary Ligament Preservation in Patients With NSCLC Undergoing Thoracoscopic Upper Lobectomy</brief_title>
  <official_title>Intraoperative and Postoperative Effects of the Preservation of the Inferior Pulmonary Ligament in Patients With NSCLC Undergoing Thoracoscopic Left or Right Upper Lobectomy（IPLP FJUNION）</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fujian Medical University Union Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Hospital of Sanming</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fujian Medical University Union Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many thoracic surgeons tend to dissect the inferior pulmonary ligament (IPL) during upper
      lobectomy, which in theory reduces the free space in the upper thoracic cavity by increasing
      the mobility of the residual lung. However, the dissection of IPL may lead to bronchial
      deformation, stenosis, obstruction or lobe torsion, distortion. Some studies have found that
      stenosis might be associated with chronic dry cough and shortness of breath, and could result
      in a significant decline in lung function. Moreover, the dissection of IPL may lead to
      greater surgical trauma and increase the incidence of complications. Therefore, this study
      tries to identify whether we should dissect or preserve the inferior pulmonary ligament
      during the thoracoscopic upper lobectomy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 23, 2020</start_date>
  <completion_date type="Anticipated">March 23, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 23, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in bronchial angle</measure>
    <time_frame>1 month and 3 months after the operation</time_frame>
    <description>change in bronchial angle of each arm(measured by IQQA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in bronchial diameter</measure>
    <time_frame>1 month and 3 months after the operation</time_frame>
    <description>change in bronchial diameter of each arm(measured by IQQA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pulmonary function reduction</measure>
    <time_frame>1 month and 3 months after the operation</time_frame>
    <description>pulmonary function reduction of each arm(mainly including FEV1,FVC and MVV)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>apical dead space</measure>
    <time_frame>1 month and 3 months after the operation</time_frame>
    <description>apical dead space of each arm(measured by IQQA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>presence of pleural effusion on chest CT</measure>
    <time_frame>1 month and 3 months after the operation</time_frame>
    <description>presence of pleural effusion on chest CT of each arm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intraoperative complication rate</measure>
    <time_frame>during the operation</time_frame>
    <description>intraoperative complication rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intraoperative mortality</measure>
    <time_frame>during the operation</time_frame>
    <description>intraoperative mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>early postoperative complication rate</measure>
    <time_frame>within 1 month after the operation</time_frame>
    <description>early postoperative complication rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>early postoperative mortality</measure>
    <time_frame>within 1 month after the operation</time_frame>
    <description>early postoperative mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>chest tube duration</measure>
    <time_frame>within 1 month after the operation</time_frame>
    <description>post-operative chest tube duration</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Lung Cancer, Nonsmall Cell</condition>
  <arm_group>
    <arm_group_label>Dissecting the inferior pulmonary ligament</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This group of patients will undergo the inferior pulmonary dessection during the upper lobe thoractomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preserving the inferior pulmonary ligament</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This group of patients will undergo the inferior pulmonary preservation during the upper lobe thoractomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dissection of the Inferior Pulmonary Ligament</intervention_name>
    <description>Patients will be categorized into two groups: the division group ,who will receive the division of the inferior pulmonary ligament, and the preservation group, who will not.For the dissection group, we will dissect the inferior pulmonary ligament during the surgery.</description>
    <arm_group_label>Dissecting the inferior pulmonary ligament</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Preservation of the Inferior Pulmonary Ligament</intervention_name>
    <description>Patients will be categorized into two groups: the division group ,who will receive the division of the inferior pulmonary ligament, and the preservation group, who will not.For the preservation group, we will preserve the inferior pulmonay ligament during the surgery.</description>
    <arm_group_label>Preserving the inferior pulmonary ligament</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age and gender: 18-75 years old, male and female unlimited;

          2. Patients with NSCLC who are eligible for video-assisted upper left/upper right
             lobectomy;

          3. Participants volunteer to participate the study and signed the informed consent form;

          4. Preoperative pulmonary function test: FEV1&gt; 1L and FEV1&gt; 60% of predicted value;

          5. Preoperative ECOG:0-1;

          6. Preoperative ASA:I-II.

        Exclusion Criteria:

          1. Women in the the period of pregnancy or lactation;

          2. Patients suffering from any serious mental illness;

          3. Having the history of any thoracic surgery (only including intrathoracic surgery,
             excluding any superficial surgery like breast surgery, etc.);

          4. Patients with unstable angina pectoris or myocardial infarction within half a year;

          5. Patients with cerebral infarction or cerebral hemorrhage within half a year;

          6. Received continuous systemic glucocorticoid therapy in the past 1 month;

          7. Abnormal coagulation function, bleeding tendency or receiving thrombolytic or
             antiplatelet treatment recently;

          8. Patients requiring emergency operation for severe lung cancer
             complication(bleeding/pneumothorax);

          9. Patients with severe hepatic,renal insufficiency or other systematic dysfunction;

         10. Other conditions that are not suitable for the surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chun Chen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Fujian Medical University Union Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bin Zheng, MD</last_name>
    <phone>13023833433</phone>
    <email>527041911@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fujian Medical University Union Hospital</name>
      <address>
        <city>Fuzhou</city>
        <state>Fujian</state>
        <zip>350001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bin Zheng, MD</last_name>
      <phone>+8659186218408</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>September 18, 2019</study_first_submitted>
  <study_first_submitted_qc>October 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2019</study_first_posted>
  <last_update_submitted>March 24, 2020</last_update_submitted>
  <last_update_submitted_qc>March 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

